Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |